about
Evaluation of pituitary function after infectious meningitis in childhood.Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study.Obesity: impact of infections and response to vaccines.Focus on GH deficiency and thyroid function.Central hypothyroidism - a neglected thyroid disorder.Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children.Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas: Focus on the Prevalence of Isolated Central Hypoadrenalism.An unusual case of recurrent autoimmune hypophysitis.Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly.Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy.Growth hormone therapy in GH-deficient adults: continuous vs alternate-days treatment.Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients.Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy.Effects of modified sham feeding on ghrelin levels in healthy human subjects.Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients.Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments.GH response to oral glucose tolerance test: a comparison between patients with acromegaly and other pituitary disorders.Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors.Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa.Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders?GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells.A new structural rearrangement associated to Wolfram syndrome in a child with a partial phenotype.Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency.Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH).Klinefelter syndrome in preschool children: the importance of an early multidisciplinary approach for patients and families.Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients.A primary adrenal non-Hodgkin's lymphoma presenting as an incidental adrenal massMayer–Rokitansky–Küster–Hauser Syndrome and 16p11.2 Recurrent Microdeletion: A Case Report and Review of the LiteratureDetection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarismEffect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic?pituitary?adrenal axis in children with idiopathic isolated GH deficiencyEffect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiencyEvaluation of the Components of the Insulin-like Growth Factors System in GH-deficient Adults: Effects of Twelve-month rhGH TreatmentA nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and managementRecombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growthAnalysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenomaVitamin D insufficiency in obese children and relation with lipid profileCabergoline Withdrawal Before and After Menopause: Outcomes in MicroprolactinomasClinically non-functioning pituitary incidentalomas: characteristics and natural historyPediatric dual-energy X-ray absorptiometry in clinical practice: What the clinicians need to know
P50
Q34333706-5F9DDBF3-20CA-4A60-AE45-6272D23F6038Q37394730-D9A061E2-0409-4B1A-B242-B3B23948A37DQ38683577-F67A881D-DDC6-4EE5-8CFD-E3DF8EE70F5EQ39287783-0C19C615-CCC3-4226-A0D4-17E0672A1CDAQ39332895-DE899C51-FFE5-4AFE-93B6-F0CFD397ADF4Q40894678-AA9AEF49-12E5-4F55-B67C-81BEE011C841Q40997563-A743039B-E5CC-4A2A-8E8D-56059ED3759EQ42458656-74989174-C9D1-4407-A257-158C189E7849Q42468096-87BCB875-7CB3-4879-9438-B7BE235729E8Q42997913-5504E0B9-5F06-453B-9769-8EAB05CF08E3Q44601435-34EB39BC-2BED-4428-A2B5-FCD5A30E45ABQ44887811-DA57FFC6-2DC8-4A3A-AC63-7CCB77DD704FQ44911454-7F378BB8-2CD8-4EC0-A3EF-010B7FA05F1CQ45096642-EA49D670-2492-4484-9780-1EC48583472EQ45142795-819F58A3-7842-4E4B-B3A8-732307722801Q46058217-06072CF0-0D72-46E5-9739-4B44BE9233B1Q46778593-58844480-4121-40EB-93A7-F48F1BCCA546Q46786619-9970544E-4384-4B01-BC2C-1CA6CCCF572CQ48051049-9274C44D-D038-4213-B575-36625EA5A9C0Q48156999-FEABF133-0EF7-491D-A355-E3DF827F6A18Q48399475-62AF4979-4BF1-4C86-80D3-27C401405433Q48421272-FC8F0CBC-5E3E-4AEB-9C94-5A0631E31F9BQ48448401-525F4DED-D726-4468-957C-23E50362E417Q48535449-1A5CB129-4360-4122-90FD-B562764A96E7Q50203394-D5CA78B4-130B-49B7-A71C-AAC14007DF6FQ50525918-41CD2854-F825-4D64-B05E-AB8D1F8750F1Q51331536-AE159061-BC96-47D3-9BD2-DA7E69579E2CQ57647850-22E48E80-8C79-4D4D-915D-5102BD3EEB69Q59395258-0AFF7437-2ADF-4D60-96E4-9BAB0811A038Q60674293-7DA77FFB-FA08-4EFA-956A-629CAA5E72C9Q61958186-E8C25E3E-35F7-4662-8B64-D1E269C734F2Q61958238-2CF04B8B-CBBC-4037-BCC1-19D342A47EB6Q61958248-A076F1E6-0121-4CE4-9A10-13945C6667F5Q64039966-AB6EA7CA-C11A-447F-96C9-4EF443B5F793Q84762642-F7E7EE3F-1500-44D2-9492-FD0399DD85B0Q85831276-8FB4B518-300A-403F-A0FF-3E4D8AFAB5D8Q86679377-9FF15EB2-FF1B-468E-BBF0-6CFD16B2E727Q90005102-A031E42F-D79E-4F3E-94A4-851BCECB9728Q90125652-8CEEBB41-8ABB-4977-A0D1-908B95B2DB78Q90287358-6F541E7B-5864-4426-9718-437384B3A0AD
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Claudia Giavoli
@ast
Claudia Giavoli
@en
Claudia Giavoli
@es
Claudia Giavoli
@nl
Claudia Giavoli
@sl
type
label
Claudia Giavoli
@ast
Claudia Giavoli
@en
Claudia Giavoli
@es
Claudia Giavoli
@nl
Claudia Giavoli
@sl
prefLabel
Claudia Giavoli
@ast
Claudia Giavoli
@en
Claudia Giavoli
@es
Claudia Giavoli
@nl
Claudia Giavoli
@sl
P214
P1053
K-8844-2016
P106
P1153
7801362258
P21
P214
P31
P3829
P396
IT\ICCU\CFIV\272593
P496
0000-0002-6787-1543
P569
1973-01-01T00:00:00Z
P735
P7859
viaf-307344204